Edwin DeJesus

19.2k citations
149 papers · 9.8k · 5 hit papers · h-index 54

Impact in

  • Virology top 0.05%
    • HIV Research and Treatment
    • HIV/AIDS drug development and treatment
    • HIV/AIDS Research and Interventions

Papers in

    • HIV/AIDS drug development and treatment 134
    • HIV/AIDS Research and Interventions 68
    • HIV Research and Treatment 119

Edwin DeJesus

147 papers receiving 9.5k citations

Edwin DeJesus's Hit Papers

Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection 2022 · 164 citations
1640+6+13Years since publication200400600

Peers

Edwin DeJesus
Comparison fields: 5 of 116
  • Virology 6.6k
  • Infectious Diseases 8.3k
  • Emergency Medicine 2.4k
  • Hepatology 969
  • Epidemiology 1.9k
Replace Donna M. Jacobsen with:
Donna M. Jacobsen United States
Patrick Yéni France
José M. Gatell Spain
Graeme Moyle United Kingdom
David A. Cooper Australia
Gilles Peytavin France
Schlomo Staszewski Germany
Keith Henry United States
Kathleen Squires United States
Chloe Orkin United Kingdom
Edwin DeJesus relative to Donna M. Jacobsen United States Donna M. Jacobsen's profile →
Citations per field
00.5×1.5×
Donna M. Jacobsen · 1×
Citations per year

Countries citing papers authored by Edwin DeJesus

Since Specialization
Citations

This map shows the geographic impact of Edwin DeJesus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edwin DeJesus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edwin DeJesus more than expected).

Fields of papers citing papers by Edwin DeJesus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edwin DeJesus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edwin DeJesus. The network helps show where Edwin DeJesus may publish in the future.

Co-authors

The 25 scholars most cited alongside Edwin DeJesus, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Edwin DeJesus Line = papers co-authored together Edwin DeJesus links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 149 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Tenofovir DF, Emtricitabine, and Efavirenz vs. Zidovudine, Lamivudine, and Efavirenz for HIV
Hit paper breakdown →
2006703
2
Maraviroc for Previously Treated Patients with R5 HIV-1 Infection
Hit paper breakdown →
2008570
3
Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial
Hit paper breakdown →
2009478
4 2012335
5 2008278
6
Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380–1490): a randomised, double-blind, multicentre, phase 3, non-inferiority trial
Hit paper breakdown →
2017278
7 2006258
8 2012256
9 2013247
10 2006223
11 2005203
12 2004201
13 2010194
14 2006184
15 2008184
16 2004175
17 2011171
18 2013167
19
Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection
Hit paper breakdown →
2022164
20 2006162

About Edwin DeJesus

Edwin DeJesus is a scholar working on Infectious Diseases, Virology, Emergency Medicine, Epidemiology and Hepatology, having authored 149 papers that have together received 9.8k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (134 papers), HIV Research and Treatment (119 papers), HIV/AIDS Research and Interventions (68 papers), HIV-related health complications and treatments (39 papers), Hepatitis C virus research (16 papers), Pneumocystis jirovecii pneumonia detection and treatment (14 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Biochemical and Molecular Research (5 papers). The work is most often cited by research in Virology (6.6k citations), Infectious Diseases (8.3k citations), Emergency Medicine (2.4k citations), Hepatology (969 citations) and Epidemiology (1.9k citations). Edwin DeJesus has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Andrew Cheng, Joel E. Gallant, Anton Pozniak, Damian J. McColl, Jeffrey Enejosa, José Ramón Arribas, Adriano Lazzarin, Peter Ruane, John J. Toole and Kirsten White. Their work appears in journals such as JAIDS Journal of Acquired Immune Deficiency Syndromes, HIV Clinical Trials, AIDS, Open Forum Infectious Diseases and The Journal of Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact